Description

AOD 9604 Vials

Introduction

AOD 9604 is a peptide fragment derived from the growth hormone, specifically the region responsible for fat metabolism. The product, AOD 9604 Vials, is designed exclusively for research purposes and should not be used for human consumption.

Key Characteristics

AOD 9604 Vials contain a synthesized peptide fragment with a molecular structure designed to investigate its potential effects on fat metabolism and related processes. These vials are carefully calibrated for research applications, adhering to strict ethical and scientific standards.

Research Applications

The primary focus of AOD 9604 Vials is on exploring its impact on fat metabolism, obesity, and its ability to mimic regenerative properties associated with growth hormone. Researchers utilize these vials to gain insights into cellular and molecular mechanisms, contributing to the advancement of scientific knowledge in the field of metabolic research.

Research Benefits

AOD 9604 May Inhibit Body Fat

Numerous studies suggest that AOD 9604 may have the potential to inhibit body fat accumulation that demonstrated significant reductions in adipose tissue mass in experimental models, supporting the hypothesis that AOD 9604 may play a role in inhibiting the buildup of body fat.

AOD 9604 and Obesity

In the realm of obesity research, AOD 9604 has shown promise and has explored the peptide’s impact on body weight and fat mass in obese animal models, indicating a potential avenue for further investigation in combating obesity-related issues.

AOD 9604 Mimics Regenerative Properties of Growth Hormone

AOD 9604 is believed to mimic some of the regenerative properties associated with growth hormones. Investigations have suggested that the peptide may contribute to tissue repair and regeneration, highlighting its potential in the realm of regenerative medicine research.

Summary

AOD 9604 Vials serve as invaluable tools for researchers aiming to expand our understanding of fat metabolism, obesity, and the regenerative properties associated with growth hormone. The carefully curated peptide fragment within these vials allows for controlled and ethical exploration of these physiological processes.

References

1. Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015 Jan;7(1):31-8. doi: 10.1002/dta.1715. Epub 2014 Sep 10. PMID: 25208511. [Read More]
2. Ng FM, Sun J, Sharma L, Libinaka R, Jiang WJ, Gianello R. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-8. doi: 10.1159/000053183. PMID: 11146367. [Read More]